SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Saxonov Serge – ‘4’ for 1/10/20 re: 10x Genomics, Inc.

On:  Tuesday, 1/14/20, at 4:04pm ET   ·   For:  1/10/20   ·   Accession #:  1209191-20-3280   ·   File #:  1-39035

Previous ‘4’:  ‘4’ on 10/15/19 for 10/14/19   ·   Next:  ‘4’ on 3/9/20 for 3/6/20   ·   Latest:  ‘4’ on 3/25/24 for 3/21/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/14/20  Saxonov Serge                     4                      1:5K   10x Genomics, Inc.                DONNELLEY FIN… File16/FA

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Form 4 Submission -- doc4.xml/3.6                   HTML      3K 




        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
Plain Text rendering:  Form 4 Submission
 
                                                                                                                                                                                
Ownership Document
 
Schema Version:  X0306
Document Type:  4
Period of Report:  1/10/20
Not Subject to Section 16:  0
Issuer:
Issuer CIK:  1770787
Issuer Name:  10x Genomics, Inc.
Issuer Trading Symbol:  TXG
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1786720
Owner Name:  Saxonov Serge
Reporting Owner Address:
Owner Street 1:  C/O 10X GENOMICS, INC.
Owner Street 2:  6230 STONERIDGE MALL ROAD
Owner City:  PLEASANTON
Owner State:  CA
Owner ZIP Code:  94588
Owner State Description:
Reporting Owner Relationship:
Is Director?  Yes
Is Officer?  Yes
Is Ten Percent Owner?  Yes
Is Other?  No
Officer Title:  Chief Executive Officer
Derivative Table:
Derivative Transaction:
Security Title:
Value:  Stock Option (right to buy)
Conversion or Exercise Price:
Value:  1.20
Transaction Date:
Value:  1/10/20
Deemed Execution Date:
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  A
Equity Swap Involved?  No
Transaction Timeliness:
Value:
Transaction Amounts:
Transaction Shares:
Value:  150,000
Transaction Price Per Share:
Value:  0.00
Transaction Acquired-Disposed Code:
Value:  A
Exercise Date:
Footnote ID:  F1
Expiration Date:
Value:  10/18/27
Underlying Security:
Underlying Security Title:
Value:  Class A Common Stock
Underlying Security Shares:
Value:  150,000
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  150,000
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Footnotes:
Footnote - F1On January 10, 2020, the Compensation Committee of the Board of Directors of the Issuer determined that certain performance targets had been achieved pertaining to a 150,000 share option granted to the Reporting Person on October 18, 2017. The option vests as to one-thirty-sixth of the shares on January 1, 2020 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
Remarks:
Owner Signature:
Signature Name:  /s/ Eric S. Whitaker, as Attorney-in-Fact
Signature Date:  1/14/20


Top
Filing Submission 0001209191-20-003280   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 2, 11:50:08.2pm ET